Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationCombined Modality TherapyGranulocyte Colony-Stimulating FactorTransplantation ConditioningMelphalanLeukapheresisAntigens, CD34Blood Component RemovalAntineoplastic Combined Chemotherapy ProtocolsTransplantation, HomologousHematologic NeoplasmsCyclophosphamideMultiple MyelomaBusulfanMyeloablative AgonistsLymphoma, Non-HodgkinTreatment OutcomeHematopoietic Stem CellsEtoposideStem Cell TransplantationThiotepaGraft SurvivalAntineoplastic Agents, AlkylatingBone Marrow TransplantationGraft vs Host DiseaseRemission InductionCytophagocytosisCarmustineIfosfamideRecurrenceVincristineStem CellsSalvage TherapyHodgkin DiseaseCytarabineHematopoiesisDisease-Free SurvivalAmyloidosisNeoplasmsDoxorubicinSurvival RateRetrospective StudiesCord Blood Stem Cell TransplantationSurvival AnalysisCarboplatinLymphoma, T-CellTime FactorsRecombinant ProteinsPrednisoneTissue DonorsPlatelet CountBlood Cell CountTransplantation ChimeraWhole-Body IrradiationInfectionAntineoplastic AgentsDexamethasoneBone Marrow PurgingHistocompatibilityFollow-Up StudiesBlood CellsLeukemia, Myeloid, AcutePOEMS SyndromeProspective StudiesHistocompatibility TestingImmunosuppressive AgentsLymphomaVidarabineFeasibility StudiesBlood Transfusion, AutologousTransplantation, IsogeneicLeukemiaCytomegalovirus InfectionsBreast NeoplasmsFatal OutcomeLeukocytes, MononuclearImmunophenotypingT-LymphocytesGraft vs Leukemia EffectBlood DonorsPrognosisCell SeparationFeverAnemia, AplasticMyelodysplastic SyndromesFlow CytometryBone MarrowHematologic DiseasesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunomagnetic SeparationLymphocyte DepletionLeukocyte CountNeutropeniaHistiocytosis, Non-Langerhans-CellMethotrexateEmbryonic Stem CellsBone Marrow Diseases